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Abstract
Background: There is a dearth of empirical evidence on the effectiveness of pharmacological and non-pharmacological
treatments for adolescents with posttraumatic stress disorder (PTSD) in developing countries. The primary aim of the
study is to examine the effects of prolonged exposure therapy compared with supportive counseling for adolescents
with PTSD delivered by nurses trained as counselors.
Methods/design: A single-blind randomized clinical trial comprising 90 adolescents with PTSD using a permuted block
design will be utilized. Nurses previously naïve to prolonged exposure and supportive counselling will be trained to
provide these treatments at the adolescents’ high schools. Data collection will last from March 2014 to December 2017
and annually thereafter, dependent on the availability of funding.
Participants will receive seven to fourteen 60 min sessions of prolonged exposure treatment (n = 45) or supportive
counselling (n = 45). All assessments will be conducted before treatment, at mid-treatment, immediately after treatment
completion, at 3-, 6-, and 12-month follow-up, and annually thereafter. It is hypothesized that PE-A will be
superior to SC in reducing PTSD symptoms at post-treatment as measured by the CPSS-I administered by an
independent evaluator. It is further hypothesized that PE-A treatment gains will be maintained at 3-, 6- and
12-month follow-ups and annually thereafter.
Discussion: While early indications are that PE-A is an effective treatment for PTSD in adolescents, this study will
help determine the effectiveness of PE-A in a South African, community setting (school-based) when task-shifted
to nurses, as compared to SC.
Trial registration: Pan African Clinical Trials Registry: PACTR201511001345372, retrospectively registered 11
November 2015.
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Background
Experiences that may be perceived as traumatic, such as
experiencing or witnessing either physical abuse, sexual
assault, or other forms of violence, are common occur-
rences among children and adolescents around the world.
In school samples in the United States, the prevalence
rates of exposure to potentially traumatic events is report-
edly between 40 and 70% [1, 2] and in a national study of
2000 children aged 10–16, 24% endorsed being victims of
physical assault, sexual assault, or kidnapping [3].
In South Africa, a study conducted in a rural setting
found that 67% of children had directly or vicariously
experienced a traumatic event [4]. Another, conducted on
10–16-year-old children in a low-income area in Cape
Town, found that 95% had witnessed violent events and
56% had experienced violence themselves [5].
In addition to prevalence studies of exposure to traumatic
experiences, the literature suggests that adolescents are at
an increased risk of developing PTSD with the diagnosis
peaking in late adolescence [6].
Two studies conducted in Cape Town, South Africa
showed that between 20 and 25% of adolescents met cri-
teria or sub-threshold criteria for PTSD [7, 8] with the
most likely pathogenic events identified as sexual assault,
physical assault by a family member, and serious accidents.
In another South African study of children and adoles-
cents (mean age of 14.3 years) exposed to at least one
lifetime potentially traumatic experience, sexual abuse was
reported in 53% of participants (42.6% females, 10.6%
males), with 64% of violations committed by perpetrators
who were known to them [9].
PTSD is often characterized by comorbidity. With the
most common co-occurring psychiatric disorder depres-
sion [10–13]. The prevalence of depression among ado-
lescents diagnosed with PTSD is reported to be as high
as 41% [1, 9]. This is much higher than the rate of de-
pression (8%) amongst their peers [1]. Other common
co-occurring diagnoses are separation anxiety disorder,
social anxiety disorder, specific phobias, panic disorder,
generalized anxiety disorder, and substance abuse disor-
ders [1, 14]. Adolescents who have been assaulted sexually
or physically may experience relationship difficulties with
peers and caregivers, weaker school performance and
behavioral issues [13]. Additionally, those with PTSD may
display anger, aggression, self-destructive behaviors, and
sexually inappropriate or high-risk behaviors [14], can feel
isolated, stigmatized, often struggle with low self-esteem
and experience difficulty trusting others [14].
Given the prevalence of PTSD in South Africa and its
chronic and debilitating effects in children and ado-
lescents if left untreated, it is a disorder that warrants
attention [15, 16]. PTSD can lead to long-term personal
suffering that reaches beyond adolescence into adulthood.
It can also have serious public health, social and economic
implications. In low- and middle-income countries
(LMIC’s) there are challenges to both access to and avail-
ability of treatment, in particular psychological treatment
[8, 17–21] for disorders such as PTSD. This dearth, among
other factors, may be attributed to the lack of available
skilled treatment providers and concerns among skilled
professionals regarding the generalizability of treatments
typically developed in higher income, ‘western’ cultural
academic settings [19].
Studies have suggested the feasibility of task-shifting
the delivery of treatment to community settings and util-
izing the services of appropriately trained and supervised
non-specialized primary care health workers (NSHWs)
[19]. Identifying effective psychological treatments that
can be delivered by NSHWs is one of the leading research
priorities in the global mental health arena [22]. To dem-
onstrate their portability, evidenced-based trials demon-
strating the effectiveness of the task-shifted treatment in
LMICs must precede their implementation [20]. The
current study aims to provide evidence that both Pro-
longed Exposure for Adolescents (PE-A) and Supportive
Counseling (SC) can be task-shifted to nurses within a
community setting for adolescents (i.e., schools).
Rationale/motivation & originality
Studies conducted to date indicate that trauma-focused
cognitive-behavioral therapy (CBT) is an effective treat-
ment for the aftermath of trauma in younger children
with sexual abuse trauma [23–29], and other types of
trauma [30–32]. Some of these studies were not ran-
domized control trials (RCTs) and most only included
younger adolescent participants. It is, therefore, prudent
to test the efficacy of trauma-focused CBT in an RCT with
adolescents spanning a wider age range (and including
older adolescents).
Prolonged Exposure (PE) therapy is a trauma-focused,
exposure-based treatment initially developed for adults
with PTSD following exposure to diverse types of trauma.
There is good empirical support for this therapy, including
many RCTs [33]. Due to the relative ease of training, PE
has been widely disseminated around the world and fol-
lowing a relatively brief training, non-specialists have been
taught to successfully provide PE [34, 35]. PE for adults
has been shown to be effective within a community setting
[35] and meets the requirements for dissemination. Pro-
longed Exposure therapy for Adolescents (PE-A), which
was based on the adult protocol, also appears to meet
these requirements as has been demonstrated in com-
munity settings in the USA [36] and in Israel [37]. The
comparator treatment, SC, is a non-trauma focused
treatment that is widely used in crisis centers and com-
munity settings to treat sexually abused children and
other traumas [26].
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A pilot and feasibility study on psychological treatment
of PTSD within a community setting (schools in Cape
Town, South Africa) utilizing the services of NSHWs
(previously treatment-naive nurses), [38] provided early
indications that task-shifting of PE-A and SC for PTSD
can be successful.
To our knowledge, there are no other published RCTs
for the treatment of PTSD in any population or age
group in South Africa. A literature review of all CBT re-
search conducted in South Africa to date, identified 15
studies, with most comprising of a single case design [39].
The proposed research aims to examine the effective-
ness of a psychotherapeutic intervention, administered
by NSHW’s, to treat the symptoms of PTSD in adoles-
cents exposed to trauma. The study aims are to compare
the efficacy of two active treatments, PE-A and SC, in
reducing PTSD and other psychopathology symptoms
(e.g., depression, anger, other anxiety disorder symptoms,
general psychopathology, and global dysfunction), and to
examine the relationship between change in PTSD symp-
toms and change in distress-related cognitions and emo-
tions (e.g., affect regulation, trauma-related cognitions,
self-attributions). We also aim to explore whether moder-
ators (e.g., pre-treatment psychopathology, education,
parental distress, resilience, self-esteem, perceived social
support) and mediators (e.g., treatment satisfaction) are
associated with treatment outcome. A further aim of the
study is to explore the ability of newly trained counselors
(previously treatment naïve), to adequately provide the
treatments by adhering to the PE-A and SC treatment
manuals. In keeping with international trends to undertake
RCTs in naturalistic settings rather than within specialist
academic institutions, the present RCT will take place
within a community setting, namely, at local schools.
A sub-sample of participants, counselors and teachers
who will be involved in the first year of treatment will be
contacted during the second year to participate in the
qualitative assessment of their subjective experiences by
using a nested qualitative component. Triangulation will
be employed as it has previously been used to evalu-
ate school mental health program efficacy [40–42] by
including semi-structured interviews and focus groups
looking at feasibility (barriers/facilitators), acceptability
(like/dislike), and impact (pros/cons) as experienced by
stakeholders. Although there is literature about the process
of seeking mental health treatment as a minor [43] and a
quantitative measure to evaluate a youth’s experience with
mental health services exists, this will be the first study de-
scribing the subjective experiences of adolescents accessing
treatment for PTSD.
The study is unique in that it will be the first RCT of
CBT in an adolescent population to be conducted within
the South African context and that involves task-shifting
by identifying counsellors, training and supervising them
in a treatment protocol that was originally intended for
use and administration by qualified specialized psycholo-
gists. It will utilize independent evaluators for the treatment
outcome assessments and will examine treatment protocol
adherence with independent fidelity ratings.
Objectives
Research hypothesis
1. PE-A will be superior to SC as administered
by counsellors in reducing PTSD symptoms at
post-treatment as measured by the Child PTSD
Symptom Scale – Interview (CPSS-I).
2. PE-A treatment gains will be maintained at 3-,
6-, and 12-month follow-up and annually thereafter
as measured by the CPSS-I
Secondary hypothesis
1. At post treatment PE-A will be superior to SC
in reducing depression, anger, anxiety, general
psychopathology, and global functioning.
2. PE-A treatment gains will be maintained at 3-,
6-, and 12-month follow-up and annually thereafter
on measures of depression, anger, anxiety, general
psychopathology and global functioning.
3. irrespective of treatment assignment (PE-A or SC),
reduction in PTSD symptoms at post-treatment will
be significantly and positively correlated with reduction
in distress-related cognitions and emotions
Primary objectives
1. To compare the effectiveness of two treatments
administered by counsellors, PE-A and SC, in reducing
PTSD symptom severity over 7–14 sessions of
treatment.
2. to assess maintenance of PE-A treatment gains on
PTSD symptom severity by conducting follow-up
assessments at 3-, 6- and 12-month follow-up, and
annually thereafter
Secondary objectives
1. To compare the effectiveness of two active treatments,
PE-A and SC, in reducing other psychopathology
symptoms (e.g. depression, anger, general
psychopathology and global functioning).
2. To assess the maintenance of PE-A treatment gains
on secondary outcomes by conducting follow-up
assessment at 3-, 6-, 12-month follow-ups and
annually thereafter.
3. To examine the relationship between change in
PTSD symptoms and change in distress related
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cognitions and emotions (affect regulation,
trauma-related cognitions, and self-attributions).
4. To assess counsellors’ adherence to the PE-A and
SC treatment manuals.
5. To evaluate the impact of moderators
(e.g. pre-treatment psychopathology, education,
resilience, severity of trauma, trauma-related
distress, parental distress, social support, self-esteem)
and mediators (e.g. treatment satisfaction, compliance,
expectation) on outcome.
6. to describe stakeholders (nurses, teachers,
adolescents) and their experiences (training,
implementation of treatment, access to treatment,
barriers, and facilitators to successful
implementation) to inform project scalability
Method
Design
The study design is reported in line with the SPIRIT 2013
Statement (Explanation and elaboration: Guidance for
protocols of clinical trials) [44].
Figure 1 provides an overview of the study design.
A single-blind permuted block randomized control de-
sign will be used. The proposed research aims to exam-
ine the effectiveness of a psychotherapeutic intervention
administered by counsellors to treat the symptoms of
PTSD in adolescents exposed to trauma. The aim is to
conduct a randomized controlled trial (RCT) to compare
PE-A to SC to determine the comparative effectiveness in
reducing PTSD and associated symptoms in adolescents.
The study will compare the efficacy of PE-A to SC. Par-
ticipation will be voluntary. All participants, who meet full
PTSD or sub-threshold PTSD criteria, will be scheduled
for a pre-treatment assessment with Independent Evalua-
tors (IE). The one IE will be an experienced diagnostician
and clinical psychologist and the other an experienced
psychiatric nurse. Adolescents will be randomly assigned
on a 1:1 ratio to receive either PE-A or SC.
Treatment will consist of 7–14 sessions of either PE or
SC. The number of sessions each participant receives
will be based on the weekly self-report measure of PTSD
symptoms (Child PTSD Symptom Scale – Self Report;
CPSS-SR); however, this will range between a minimum
of 7 sessions to a maximum of 14 sessions. A 70% symptom
reduction is chosen as sufficient for treatment termination.
After session five, all participants will receive a mid-
treatment evaluation by the IE. The IE will again assess
the participants upon termination of treatment. Partici-
pants will then enter the non-treatment follow-up phase.
Participants who prematurely terminate therapy (before
70% symptom reduction or 7 sessions) will undergo a
post-last session assessment with the IE and will then
enter the follow-up phase. Follow-up assessments will be
conducted at 3-, 6-, and 12 months post-treatment and
annually thereafter. The IE assessments will comprise
both structured clinical interviews and self-report
measures. The assessments will cover PTSD severity,
related psychopathology, general psychopathology, and
PTSD-related cognitions. At the 12-month follow-up,
participants who receive SC and are deemed to still
have clinically significant PTSD symptoms (as determined
by the IE at 12-month follow-up assessment), will be
offered PE-A. To add to the rigor of the study and demon-
strate the long-term efficacy of the intervention, there will
be annual posttreatment follow ups, dependent on the
availability of funds for this purpose.
A cross-sectional qualitative evaluation will take place
during the follow up assessments of the adolescents who
have completed their treatment. Adolescents who partic-
ipated in the study in the preceding year (regardless of
completion or outcome) will be invited to participate in
semi-structured interviews with an independent psycholo-
gist. Similarly, there will also be separate focus groups for
the nurse counsellors and the contact persons at the schools
who had been part of the study during the preceding year.
Ethics approval
This study has been approved by the Health Research Eth-
ics Committee at Stellenbosch University (N12/06/031)
and will be conducted according to the ethical guidelines
and principles of the international Declaration of Helsinki,
South African Guidelines for Good Clinical Practice and
the Medical Research Council (MRC) Ethical Guidelines
for Research.
Permission was also obtained from the Western Cape
Education Department (WCED) to offer treatment at
the participants’ schools. Permission from the WCED
was conditional on not disclosing the identities of the
participating schools.
Consent will be obtained from parents of potential
participants in the study. Informed consent and assent
will be obtained by the IE when determining eligibility
and prior to randomization to treatment. A participant
may leave the study at any time. Study procedures as
well as potential risks, benefits and treatment alterna-
tives will be explained at the time participation in the
study is discussed. Participants will be clearly informed
of the voluntary nature of their participation and their
right to terminate without any penalty.
The one IE, an experienced Clinical Psychologist, will
screen participants for other psychopathology and will
not include a potential participant if the principal diagnosis
is not PTSD in response to a traumatic event.
Participating schools’ headmasters and educators will be
informed that the study entails the treatment of adolescents
that have experienced a trauma. In this way adolescents will
not be identified in terms of the nature of their trauma.
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Counsellors will keep all study and personal information
about participants confidential.
Participants will receive all written material in their
language of choice (Afrikaans, English and Xhosa).
All counsellors will receive weekly supervision, on every
participant under their care. Counsellors will have unre-
stricted access to the supervisor. Participants in both
PE-A and SC will be informed that they can contact their
counsellor between sessions should they experience a
crisis or are distressed enough to need support. If a
counsellor is concerned about a participant’s psychological
welfare, the supervisor will arrange for a psychological
assessment. Although unlikely, should significant negative
emotional reactions develop that require other forms of
intervention, the participant will be withdrawn from the
study and will be appropriately referred.
Fig. 1 Study Consort Diagram, Consort diagram
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Should the parent be unable to provide informed consent
in person for the qualitative addition to the study, the
following procedure will be used:
1. Parent contacted by telephone, given information,
and read the consent form. Parent will be given
opportunity to ask questions. Consent via the
telephone will be recorded.
2. Teenager will be picked up for interview. Before the
interview begins, the child will provide their written
assent.
3. When the teenager leaves the interview, he/she will
take the informed consent form/information letter
home for the parent to sign. A witness will co-sign
the consent form.
4. to be picked up for the focus group, the child must
show the driver a signed copy of the consent form.
The consent form will be collected at the focus
group and a copy will be sent back with the
teenager for the parent’s records
Participants
Adolescents aged 13 to 18 years, who have experienced
an interpersonal trauma, will be included in the study. Ado-
lescents must present with chronic (at least 3-months) full
PTSD or sub-threshold PTSD to be included. Sub-threshold
PTSD is defined as having at least 1 re-experiencing symp-
tom, at least 2 avoidance symptoms, 2 arousal symptoms
and a score of 11 on the CPSS. Providing that PTSD is
deemed to be the primary disorder requiring treatment, ad-
olescents with comorbid mood disorders, anxiety disorders,
substance use disorders and ADHD will also be included.
Adolescents with conduct disorder, a primary substance
abuse problem and psychotic disorders will be excluded.
For the qualitative study, stakeholders should have
been involved in the study during the previous year (to
make sure that they still remember their experiences).
Stakeholders will be included even if; a) the adolescent
did not complete the treatment intervention; b) the nurse
did not complete the yearlong commitment; c) the nurse
did not gain experience in implementing both treatment
strategies; or, d) the school did not yield any recruits.
Recruitment
Participants for the RCT will be adolescents recruited
from lower socio-economic status community schools
around Cape Town. A recruiter will address the children
during assembly and in individual classes. The recruiter
will explain the definition of a traumatic event, will de-
scribe typical events that would be considered a qualify-
ing traumatic experience, will explain the diagnosis of
PTSD and explain that this study aims to compare the
effectiveness of two treatments when administered by
nurses within the community (school). Adolescents who
think that they could benefit from treatment will complete
a PTSD screening instrument in private. Prospective
participants who indicate that they have experienced a
trauma and whose scores are beyond the cut-off for inclu-
sion will be scheduled for a pretreatment assessment. For
those who meet the criteria, a pre-assessment interview
will be scheduled with the adolescent and their parent or
guardian.
In the nested qualitative study, adolescents completing
treatment in the preceding year will be invited to partici-
pate in a treatment specific focus group with similar
adolescents and will participate in individual interviews.
The topic guide and other standard operating proce-
dures may be seen in (Additional file 1: Table S4 – S4c).
Nurses/counsellors who had been trained in the pre-
vious year will be invited to attend a focus group
(Additional file 1: Table S5 – S5c) and similarly, contact
persons at school (teachers) will be invited to attend a
focus group for representatives from host organizations
(Additional file 1: Table S6 – S6b). All stakeholders who
will have been involved in that time frame will be con-
tacted by phone to set up an information/informed con-
sent session for the qualitative portion of this study.
Procedure
Counsellors will be sourced from a one-year advanced
diploma in psychiatric nursing student group at the
University of Stellenbosch. The definition of a counsellor
for the purpose of this study will be a qualified nursing
sister. Both treatments (PE-A and SC) will be provided by
each of these counsellors to prevent confound of therapist
effects. The nursing sisters will only be reimbursed for
petrol/transport costs. Counsellors will be identified and
trained every year. This will result in counsellors not see-
ing more than 4 participants each, thus remaining rela-
tively inexperienced over the period of the study.
The training will be 4 days in duration, 3 days devoted
to training in the PE-A protocol and the 4th-day to
training in SC. The SC training will be followed by an
additional 16 h of practical training. The training will
culminate in the ability to implement the PE-A and SC
skills following the two treatment manuals, respectively.
Every counsellor will have a file with all the information
needed for each participant they are treating. Counsellors
will, therefore, be able to follow the treatment steps and
have all the information required at the ready for every
participant. Weekly supervision will occur throughout the
duration of the study.
Identified individual participants enter a pre-treatment
preparation phase conducted by an IE. During this time
the IE will explain the study (nature of treatments, ran-
dom assignment, duration of treatment, measures and
follow-up procedures), obtain informed consent, and
address logistical issues.
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Participants will be randomly assigned to a counsellor
and to a treatment condition. The randomization sched-
ule will be created by an independent statistician and
only provided to the project coordinator. The project co-
ordinator, the only one with access to the randomization
scheme, will contact the counsellor. The counsellor will
be informed of the treatment condition that the client
has been randomly assigned to. The counsellor will
contact the school and the adolescent and set up the
first appointment. Both treatments will be administered
by the counsellors within the high-school setting.
Following the pre-treatment preparation, both PE-A
and SC will consist of 7–14 sessions, lasting 60 min each.
The CPSS-SR will be administered at the beginning of
each session in order to monitor treatment progress.
From session 7, the percentage improvement from the
pre-treatment baseline will be measured. When improve-
ment reaches 70% or better, the counsellor will share the
outcome with the participant and start the termination
process.
The follow-up assessments will be administered by an
IE blind to the treatment condition.
Monitoring treatment integrity
All treatment sessions will be video recorded. Ten per-
cent of treatment sessions will be randomly selected for
protocol adherence ratings. Oversampling will take place
on the sessions in which the rationale of SC or PE-A is
explained to track adherence to the protocol during
these critical sessions. Counsellors will make note of any
mention of the trauma during the SC sessions.
Qualitative portion of study
Adolescents who agree to participate in the study will be
interviewed by an independent evaluator and will partici-
pate in a treatment specific focus group. These interviews
will be audio-recorded.
The focus groups with the nurse counsellors and school
contact personnel will be conducted at Stellenbosch Univer-
sity by an independent clinical psychologist. A co-facilitator
will record field notes and manage the audio-recording.
The PE-A treatment group
The PE–A program consists of 7 to 14 weekly, 60 min
sessions. Treatment comprises 8 modules. Homework
exercises provide the opportunity for practice outside of
the session. Module 1 includes presentation of the treat-
ment rationale. Module 2 includes information gathering,
identifying an index trauma, and conducting a breathing
retraining exercise. Module 3 presents common reactions
to trauma. Module 4 includes discussion of the rationale
for in vivo exposure (confronting trauma reminders in real
life), construction of the in vivo hierarchy, and assignment
of in vivo homework. Module 5 includes presentation of
the rationale for imaginal exposure (revisiting and recount-
ing the traumatic memory), conducting imaginal exposure
for 15 to 45 min, and processing this revisiting experience.
This module is repeated for 2 to 5 sessions. In module 6,
the imaginal exposure focuses on the worst moments of
the trauma. Module 6 is repeated for 4 to 7 sessions.
Module 7 focuses on generalization of skills learned in
treatment and on relapse prevention. Module 8 comprises
a “final project,” such as making a collage detailing the
trauma and the gains made in treatment.
Table 1 provides a detailed outline of the PE-A treatment.
The SC treatment group
SC consists of 7 to 14 weekly, 60 min sessions of
client-centered therapy. SC is based on the Traumagenic
Dynamics Model of symptom formation after child sexual
abuse and the Rogerian psychotherapy model. Support-
ive counselling sessions focus on establishing a trusting,
empowering, and validating therapeutic relationship. Par-
ticipants are allowed to choose when, how, and whether
or not to address their trauma. In session 1, participants
are oriented to SC.
Counsellors provide active listening, empathy, and en-
couragement to talk about feelings and express beliefs in
the participant’s ability to cope. Participants direct the
sessions. Counsellors note discussion of the trauma and the
time devoted to such discussions. Tools such as problem
solving and keeping a diary will be taught to participants.
Table 2 provides a detailed outline of the SC treatment
program.
Measures
A pilot study of 12 participants [38] was used to determine
the final assessment battery (from the included battery)
that will be used for the study. The pilot study was also
used to identify any logistical or treatment protocol imple-
mentation difficulties.
The assessment battery that will be administered to all
adolescents who are eligible on screening is detailed
below in Table 3.
All measures will be obtained by an IE at baseline,
mid-treatment (after 5 sessions), and post-treatment,
and again at 3-month, 6-month and 12-month follow-up,
and in following years at annual intervals, dependent on
the availability of funds.
Diagnostic information
The Medical Research Council Demographic Question-
naire (MRCDQ) The MRCDQ will be used to obtain
each adolescent’s age, grade, gender and alcohol and drug
use history from the adolescent, educator or parent. Infor-
mation on the parents will include, age, educational level,
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marital status, income, employment, and their alcohol and
drug use history.
The Mini International Neuropsychiatric Interview
for Children and Adolescents (MINI-KID; [45]) The
MINI-KID is a semi-structured interview, administered
by a trained clinical interviewer, covering current and
lifetime disorders. It has excellent test-retest reliability
(0.64–1.00).
Psychopathology measures
The Child PTSD Symptom Scale–Interview (CPSS-I;
[46]) The CPSS-I will be used in conjunction with the
MINI-KID to assess PTSD diagnosis and PTSD symptom
severity. The CPSS interview (8–18 years), is based on
DSM-IV criteria and provide a Total-, re-experiencing-,
avoidance- and hyperarousal score. The CPSS-I has 17
items that correspond with the DSM-IV and an additional
7 items. The CPSS-I Total score ranges from 0 to 51 and
each item is rated from 0 to 3. Internal consistency ranged
from .70–.89 for the total and symptom cluster scores.
Test-retest reliability was good to excellent (.84 for the
total severity score, .85 for re-experiencing, .63 for avoid-
ance and .76 for arousal). Convergent validity was high
(.80) between the CPSS and the Child Posttraumatic
Stress Reaction Index [47]. A cutoff Total score of 11 or
higher on the CPSS yielded 95% sensitivity and 96% speci-
ficity of diagnosis. The CPSS-I Total Score will be used as
the primary outcome measure.
Table 1 Outline of PE-A treatment, A detailed outline of the PE-A treatment
Major focus Goals Sessions (ideal) Present at session
Phase 1: Psychoeducation and treatment planning
Module 1: Treatment Rationale
Tool 1: Breathing Retraining
1. Build rapport
2. Give overview of treatment
3. Introduce treatment rationale to the
adolescent and the parent or guardian




Module 2: Gathering Information Gather information as the adolescent tells
about the traumatic event.
1,2 Adolescent
Module 3: Common Reactions 1. Describe common reactions
2. Discuss the adolescent’s own reactions
to trauma
2, 3 Adolescent, Guardian
(partial)
Phase 2: Exposure
Module 4: Rationale for Exposure
Tool 2: Real Life Experiments
Tool 3: Stress Thermometer
1. Review rationale for real-life experiments/
In –vivo Exposure




Module 5: Dealing with avoidance.
Tool 4: Construction of hierarchy for
real life experiments
1. Create in vivo hierarchy
2. Choose an initial target for in vivo exposure
3,4 Adolescent, Guardian
(partial)
Module 6: Recounting the trauma
Tool 5: Imaginal Exposure
1. Explain why it is helpful to recount the
memory of the trauma
2. Reliving the memory through writing
or talking
4,5,6,7 Adolescent
Module 7: Recounting the Trauma
Tool 6: Worst Moments
Process the most difficult parts of the memory 7,8,9,10, 11,12,13 Adolescent
Phase 3: Relapse Prevention and Graduation
Module 8: Generalization and Relapse
Prevention
1. Review progress
2. Discuss the efficacy of various tools acquired
in therapy.
3. Introduce generalization training and relapse
prevention
4. Discuss the outcome of the therapy
10,11,12,13, or 14 Adolescent, Guardian
(partial)
Module 9: Graduation 1. Review Progress with Parents/Guardians
2. Celebrate accomplishments
3. Reiterate Relapse Prevention Strategies
10,11,12,13, or 14 Adolescent, Guardian
(partial)
Modules 1–9: Family intervention 1. Foster relationship with guardian(s)
2. Inform the Guardian about the progress
of treatment.
3. Address obstacles to treatment.
Family interventions are included in each module.
Up to 3 additional sessions as necessary to meet
goals of the module. To include parents with or
without adolescent.
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The Child PTSD Symptom Scale – Self Report
(CPSS-SR; [46]) The CPSS-SR is a self-report version
with psychometric properties that are equivalent to the
CPSS-I and will be utilized in every session as a repeated
measure of PTSD symptoms and will also be part of the
pre-treatment assessment package. It will be administered
weekly as a self-report to monitor treatment progress and
will be used to decide when to terminate treatment.
The Children’s Global Assessment Scale (CGAS; [48])
The CGAS will be used by the IE to provide a measure-
ment of general functional impairment and as a second-
ary outcome measure by the IE. It is an appropriate tool
for children from age 4–18. The CGAS has demon-
strated good inter-rater reliability (r = .85) when admin-
istered by trained clinicians.
The Beck Depression Inventory (BDI; [49, 50]) The
BDI, which has been normed for adolescents, will be
used to assess depression. The BDI split half-reliability is
.93, and correlations with clinician ratings of depression
range from .62 to .65 [49]. The BDI will be used by the
IE as a secondary outcome measure.
The Spielberger State-Trait Anger Expression Inventory-2
(STAXI-2; [51, 52]): 1999) The STAXI-2 is a 57 item
self-report measure. It has a State-Anger subscale
measuring the intensity of angry feelings and the extent
to which a person feels like expressing anger at a par-
ticular time and the STAXI Trait-Anger scale that mea-
sures how often angry feelings are experienced over
time, using a 4-point Likert scale. Anger control is mea-
sured by presenting descriptions of responses and partic-
ipants rate how often they behave in the manner
described when angry, also using a 4-point Likert scale.
Norms are available for adolescents 16–19 years of age.
Internal consistency (.88) is good. High scores on the
STAXI-2 scales (75th percentile) indicate anger experience
and expression that interferes with normal functioning.
The STAXI-2 will be incorporated as a secondary measure.
The Child Behavior Checklist-Youth Self Report
(CBCL-YSR; [53]) A 112-item self-report screening tool
for behavioural and emotional problems in children and
adolescents. In this study, we report the Externalizing,
Internalizing and Total Problem scores. Raw scores are
converted to T-scores. On all three scales, a T-score of
70 and above is in the ‘Clinical’ range. A T-score of 65–69
is in the ‘Borderline Clinical’ range. It is normed for ages
11–18. The Total Problem Score has been shown to have
excellent test-retest reliability (.87). The Total Problem
Score, Internalising behaviour and Externalising behaviour
scales will be used by the IE as secondary measures.
Table 2 Outline of SC treatment, A detailed outline of the SC treatment
Major Focus Goals Sessions (ideal) Present at session
Phase 1: Psychoeducation and treatment planning
Module 1: Information gathering and
Treatment Rationale
1. Build rapport
2. Gather information about the trauma
3. Give overview of treatment
1,2 Adolescent, Guardian
(Full or partial)
Module 2: Treatment Planning
Tool 1: Daily Diary
1. Gathering information about everyday
problems
2. Give the rationale for supportive counseling




Module 3: Crisis Intervention and Coping
Tool 2: Positive Problem Solving
1. Review Daily Diary
2. Provide Support
3. Practice Problem Solving
3–9 or 13 Adolescent
Phase 3: Relapse Prevention and Graduation
Module 4: Generalization and Relapse Prevention 1. Review progress
2. Discuss the efficacy of various tools acquired
in therapy.
3. Introduce generalization training and relapse
prevention
4. Discuss the outcome of the therapy
10.11.12.13,or 14 Adolescent Parent
(partial)
Module 5: Graduation 1. Review Progress with Parents/Guardians
2. Celebrate accomplishments
3. Reiterate Relapse Prevention Strategies




1. Foster relationship with parent (s)
2. Inform the parents about the progress of
treatment.
3. Address obstacles to treatment.
Throughout the treatment. Up to 3 additional
sessions as needed to include parents with or
without adolescent.
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The Multidimensional Anxiety Scale for Children
(MASC; [54, 55]) The MASC is specifically designed to
assess a wide spectrum of common anxiety symptoms in
youth. The items are distributed across 4 major factors;
physical symptoms, social anxiety, harm avoidance and
separation anxiety the ratings are done on a 4-point
Likert rating scale. The scale has been shown to be
invariant across gender and age and shows excellent in-
ternal consistency and test-retest reliability [53]. A study
showed that the same 4-factor structure applies to ado-
lescents in the Cape Town metropole, when compared
to North American and Icelandic samples [55]. Another
important finding was that the 4-factor structure applied
equally well to males and females, making between group
comparisons possible within this context. The MASC also
measures separate dimensions of anxiety amongst various
racial groups, which makes it suited to discriminate patterns
of anxiety in subgroups of youth with anxiety disorders.
The Personal Experience Screening Questionnaire
(PESQ; [56]) This measure was developed as a screening
tool for drug use in adolescents. This scale provides a
global measure of problem severity, by indicating to
what extent adolescents are psychologically and behav-
iourally involved with drugs. The score on the problem
severity scale varies from 0 to 54, with a score of 30 indi-
cating a problematic level of drug use. Internal consistency
ranges from .90 to .95 across normal, delinquent and sub-
stance-abusing adolescents. The PESQ Problem Severity
score will be used as a secondary measure by the IE.
Cognition and emotion measures
Three measures of dysfunctional cognitions related to
trauma will be administered to investigate the role of
cognition in mechanisms of change:
The Child Post-Trauma Attitudes Scale (C-PTAS; [57]
This is a 30-item self-report measure for children 8 and
older and generates a total score and 3 subscale scores
for negative post-traumatic cognitions. The subscales
measure perceptions about the dangerousness of the
world, a sense of own competence, and isolation. The
measure also yields a total score which ranges from 0 to
120. Internal consistency was moderate to high, with
alphas ranging from .66 to .82 for the total C-PTCAS
score and three subscales. The C-PTAS will be used as a
secondary measure by the IE.
Table 3 Measures used in assessment, Measures used and indication when used in assessment








Diagnostic Information MINI-KID [45] PTSD and other symptoms IE 90 X
MRC Demographic Questionnaire Demographic Information Parent 10
Psychopathology CPSS [46, 47] PTSD severity IE 10 X X X X
CGAS [48] General Functioning IE 5 X X X X
BDI [49, 50] Depression Adolescent 10 X X X X
STAXI [51, 52] Anger Adolescent 10 X X X X
CBCL-YSR [53] General psychopathology Adolescent 20 X X X
MASC [54, 55] Anxiety Adolescent 5 X X X X
PESQ [56] Substance use Adolescent 15 X X X X
Cognition & Emotion C-PTAS [57] Trauma-related cognitions Adolescent 10 X X X X
CAPS [58] Attributions and perceptions Adolescent 10 X X X X
PTCI [66] Trauma-related cognitions Parent 10 X X X
NMR [59, 60] Affect Regulation Adolescent 10 X X X
MSPSS [61, 62] Social support Adolescent 10 X X X X
Rosenberg [63] Self-esteem Adolescent 3 X X X X
CD-RISC [64] Resilience Adolescent 5 X X X X
Symptoms – Parents PDS [65] PTSD Parent 20 X X X
BDI [49, 50] Depression Parent 10 X X X
Treatment variables Expectancy-A Tx expectancy Adolescent 2 X
Satisfaction-A Tx Satisfaction Adolescent 2 X X X
CPSS [41] PTSD severity Adolescent 10 Every session
Treatment compliance Compliance with the treatment Therapist 2 X X X
Rossouw et al. BMC Psychiatry  (2018) 18:288 Page 10 of 16
The Children’s Attributions and Perceptions Scale
(CAPS; [58] The CAPS is an 18-item scale that has been
normed as an interview but will be used as a self-report
measure. The CAPS rated on a 5-point Likert Scale has
four subscales: Feeling Different from Peers, Personal
Attributions for Negative Events, Perceived Credibility,
and Interpersonal Trust. Internal consistency for the
subscales ranges from .63 to .73. Test-retest reliability
ranges from .60 to .82 for the subscales and is .75 for the
total scale.
The Negative Mood Regulation questionnaire (NMR;
[59]) This is a 30-item measure of beliefs that individ-
uals have, which, when they are in a bad mood, can
effect a change to help them feel better. Higher scores
indicate better expectancies around the ability to control
negative mood. Test-retest reliability for the NMR was
acceptable (.67–.78). Although this measure was not
designed specifically to be used in adolescents, it has
been used successfully in studies of depressed suicidal
and non-suicidal adolescents [60]. The NMR will be
used as a secondary measure by the IE.
Additionally, the following three adolescent self-report
measures will be administered:
The Multidimensional Scale of Perceived Social Support
(MSPSS; [61, 62] The MSPSS is a 12-item self-report in-
ventory that measures the perceived adequacy of social
support from 3 sources; family, friends and significant
other. The ratings are made on a 7-point Likert-Scale.
The psychometric qualities of the MSPSS were evaluated
within a South African context with the internal reli-
ability of the scale and subscales found to be high
(Cronbach alpha coefficients > 0.85) [62]. The MSPSSis
psychometrically sound and has excellent internal
validity in South African youth.
The Rosenberg Self-Esteem Scale [63] This is a 10-item
self-rating scale to assess self-esteem. The ratings are
done on a 4-point Likert scale. The scale has been evaluated
across multiple cultural contexts [63], including Western,
Eastern and African contexts.
The Connor-Davidson Resilience Scale (CD-RISC; [64]
The CD-RISC is a 25-item self-report measure to assess
resilience. Ratings are done on a 5-point Likert Scale.
Parental symptoms - moderators
Parental distress will be assessed as moderators of out-
come. If parents themselves suffer from PTSD following a
trauma, they might interfere with the exposure procedures.
The Posttraumatic Diagnostic Scale (PDS; [65] The
PDS will be used to measure the total and subscale
severity scores and categorical classification of PTSD.
The Beck Depression Inventory (BDI; [49, 50] The BDI
will assess depression as it can be widely used in a variety
of populations, including trauma victims [67] and the.
The Post-Traumatic Cognitions Inventory (PTCI; [66]
The PTCI is a 36-item self-report instrument that
assesses dysfunctional post-trauma cognitions. Items are
rated on a 7-point Likert Scale; this will be completed by
the parent/guardian.
Treatment related variables - mediators
Three self-report measures will be administered to exam-
ine their mediating effects on treatment outcome:
Expected Treatment Outcome (ETO) will be provided
by the adolescent on a 5-point Likert scale from “I
expect this treatment to help me a lot” (5) to “I
don’t expect this treatment to make any difference
in my condition” (1).
Treatment satisfaction (WIAC) will be provided by the
adolescent on a 5-point Likert scale from “I am extremely
satisfied with this treatment, it helped me a great deal”
(5) to “I am not at all satisfied with this treatment, it did
not help my condition” (1).
Treatment Compliance will be assessed by the
counsellor by ranking the adolescent’s compliance with
treatment and homework on a 5-point Likert scale.
Qualitative study
Topic guides and interview schedules for the different
qualitative groups are included in (Additional file 1: Table
S4 – Table S6c). The Standard Operating Procedures
(SOP) for adolescents, the initial telephone contact pro-
cedure with the adolescent’s parent, and the interview
schedule and focus group topic guides to be used in the
qualitative interviews can be found in (Additional file 1:
Table S4, S4a and S4b). The SOP outline for the nurse
counsellors, the initial telephone contact, the focus group
topic guide and a questionnaire to be completed can be
found in (Additional file 1: Table S5, S5a, S5b and S5c).
The details of the SOP for teachers, the initial telephone
contact and the focus group topic guide can be found in
(Additional file 1: Table S6, S6a and S6b). The SOP for
data coding and thematic analysis are presented in
(Additional file 1: Table S7) and the details of the
SOP for transport arrangements of participants to the
Stellenbosch University Medical Campus are presented in
(Additional file 1: Table S8).
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Data management and monitoring
Acquired data will be entered immediately into a data-
base constructed using SPSS. Each entry form will be
restricted to the possible range of items. Data entry and




Demographic characteristics and outcome measures at
pre-treatment assessment will be examined using t-tests
(for continuous variables) or chi-square tests (for nominal
variables). These comparisons will enable the identifica-
tion of control variables for use in later analysis for com-
paring treatment differences. The focus will be on both
statistical and clinical significance of group differences
(means and proportions of variants explained).
General considerations for data analysis
Descriptive statistics will be gathered in order to deter-
mine if variables have a normal distribution and variables
that violate assumptions of normality will be transformed.
If this does not improve the normality of distribution,
distribution free statistics will be used.
The study has pre-, mid-, post-treatment, three follow-up
assessments and annual follow-up thereafter. This creates
clustered data due to repeated measures. To examine treat-
ment difference, generalized estimating equations (GEE)
and a linear mixed-effects model approach (LMM) will be
employed. Both approaches accommodate missing data.
LMM will be the main analytical tool, particularly for esti-
mating between-participant variability; GEE will be used to
assess the robustness of the population parameters, such as
treatment effects.
Analyses correlating the change in PTSD symptoms
with each of the distress-related cognition and emotion
variables at post-treatment will be performed, by pooling
data across treatment conditions. Product-moment and
Spearman’s rho correlation coefficients will be used.
Correlation analyses correlating the change in PTSD
symptoms with each of the distress- related cognition and
emotion variables at post-treatment, by pooling data across
treatment conditions, will be performed. Product-moment
and Spearman’s rho correlation coefficients will be used.
Exploratory analyses
Moderators such as (pre-treatment psychopathology, edu-
cation, resilience, self-esteem, perceived social support, type
of trauma (sexual assault vs. physical assault), treatment ex-
pectancy and mediators (treatment satisfaction, treatment
compliance, and amount of time spent with guardians in
treatment sessions) will be explored to determine if they
are related to treatment outcome.
In each analysis a time-by-treatment-by-moderator inter-
action for each of the moderators will be investigated. For
each mediator, structural equations models (SEM) to model
the mediated relationship to treatment conditions and each
primary outcome of interest will be performed. With three
assessment points at pre-, mid- and post-treatment, there is
only one direct and one indirect effect of treatment condi-
tion on the response at post-treatment [67–69].
Thematic analysis procedure for qualitative aspect
All audio-recordings from interviews and groups will be
independently transcribed twice, once by the facilitator
and once by a research assistant. Anticipated themes will
be informed by the topic guides/interview schedules
(feasibility, acceptability, impact, barriers, facilitators).
Thematic content analysis will be done using Atlas.ti
software (Additional file 1: Table S7).
Sample size
It is believed that the within-group effects for both PE-A
and SC in this study will be comparable to the effect
sizes in previous studies examining these treatments in
children and adolescents and adults [26, 36, 68, 69].
Using these data, it, is suggested that a total of 64 com-
pleters is necessary to provide 80% power for a two-tailed
alpha level of 0.1. The literature suggests that as many as
30% of PTSD study entrants will terminate prematurely,
i.e., drop out. A total of 90 entrants will thus result in 64
completers.
Discussion
This is the first RCT using evidence-based CBT for
PTSD in traumatized adolescents within a South African
context. In addition, the study will be assessing the
effectiveness of task shifting in a limited resource envir-
onment, using counsellors with minimal to no previous
experience in psychosocial treatment of PTSD, which
will be vitally important from a public mental health
perspective. Should the results of this study demonstrate
that PE-A is an effective psychotherapeutic intervention
for treating symptoms of PTSD in adolescents exposed
to trauma, when administered by trained counsellors,
the implications for treatment recommendations may be
wide-ranging. Thus, community-based personnel could be
trained relatively easily to deliver the treatments within
the sufferers’ environment, which in turn, would make
effective treatments more readily accessible as well as
more cost-effective.
Potential risks
(i) Participants can develop mild to moderate emotional
discomfort or frustration associated with interviewing,
or completing lengthy questionnaires; (ii) participants
may experience subjective distress during treatment; (iii)
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all participants are exposed to the risk of relapse during
the non-treatment follow-up; and, d) participants might
suffer from stigma at the schools they attend.
There is the risk that some participants accidentally
state identifiable information on the recording device
that is recognizable by the research assistant-transcriber.
During focus groups, (i) participants may experience
mild emotional discomfort in situations where there are
differences of opinion from theirs or (ii) when talking
about aspects of treatment. (iii) Adolescents may be
disappointed that they did not have the same therapeutic
experience as another participant or (iv) they may fear
being recognized by a fellow participant.
The risks for nurses is that they may experience anxiety
concerning negative consequences in relation to voicing
dissatisfaction about training and/or supervision conducted
by the PI.
Protection against risks
Participants not deemed study eligible (see exclusion cri-
teria) or who themselves do not assent or their parents
or guardians do not consent to participation in the study
will be offered clinically appropriate treatment referrals
outside the study.
Prior to exposure-based interventions, informed con-
sent/assent will be obtained from eligible adolescent par-
ticipants to reduce possible risks of mild to moderate
anxiety when exposed to anxiety-provoking images and
situations in treatment sessions, at home or doing home-
work. Each participant will be given a rationale for PE and
advised of the procedure and the temporary effects that
the procedure might have. Participants will be required to
give assent prior to every exposure session or task. Expos-
ure therapy has been shown to provide benefits. While
some individuals fail to benefit from an intervention, very
few report adverse effects. The exposure is individually
titrated; in-vivo exposure starts with situations that elicit
moderate anxiety and progress to more anxiety-provoking
situations and triggers.
Risks associated with SC may include non-reduction
of PTSD symptoms. All participants in this treatment
condition who retain a PTSD diagnosis or manifest sig-
nificant trauma-related symptoms, will be offered PE-A
at the end of treatment.
In the nested qualitative study, to manage potential
emotional risks, the focus groups and interviews will be
conducted by a clinical psychologist. Participants will be
encouraged to use code names while the recording is on
and the recording will be identified by a code. Only the
two transcribers will have access to the audio-recordings
and transcribe using earphones in a private location.
Transcribers will sign a confidentiality agreement. All
identifiable information will be removed from the
transcription prior to analysis. The PI will not be present
during the focus group discussions and all feedback to
him will be de-identified.
Adolescents will attend intervention specific (PE-A or
SC) focus groups to protect them from exposure to an
unfamiliar treatment experience. If there are enough
interested adolescents, the groups can be further sepa-
rated based on gender. Rules regarding confidentiality
and respect will be reinforced throughout focus groups.
Participants’ reactions to study assessments and treat-
ment will be closely monitored, and negative reactions
will be addressed therapeutically. To avoid or reduce mild
to moderate emotional discomfort or frustration associated
with psychiatric interviewing or filling out questionnaires,
adolescents and their parents will be allowed breaks as
needed during in the assessment phases. Additionally, the
intake assessment can be spaced over visits, if needed.
Participants in both conditions will be informed by
their respective counsellors that they may call between
sessions should they experience a crisis or are distressed
enough to need psychological support. If a counsellor
becomes concerned about a participant’s psychological
welfare, contact will be made with the supervisor and PI
who will arrange for psychological evaluation. Although
unlikely, if substantial negative emotional reactions de-
velop that require additional interventions, participants
will be withdrawn from the study and referred to public
health treatment providers to receive these services. Such
identification can be made by IEs or study counselors, in
consultation with the PI.
In cases where danger to self or others is identified,
the adolescent will be withdrawn from the study and
clinically appropriate emergency service procedures will
be implemented. If previously undocumented sexual or
physical abuse is discovered during consent or treat-
ment, we will implement standard procedures for notify-
ing the appropriate social services and provide referrals
to local public mental health treatment centers. If a social
work referral is required during treatment, the adolescent
may or may not be continued in the study depending on
what is in the best interest of the participant. This decision
will be made by the PI and the treatment team in consult-
ation with the adolescents’ primary caregiver, provided
that this caregiver is not the perpetrator.
All study data will be confidential. The following steps
will be taken to minimize risks to confidentiality: a)
evaluation protocols and treatment record forms will be
kept in locked cabinets in the IE office; b) participant
identity will be disguised using ID numbers keyed to a
master list; c) all recordings will be transferred to remov-
able storage that will be kept in locked storage in locked
rooms; d) data will be entered directly onto computer files
that will be password protected; and e) computer files will
carry only participant numbers for case identification. All
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project staff will be trained in the importance of confiden-
tiality. If the results of the study are published, data that
might reveal the identity of a participant will be disguised.
Data safety and monitoring review board
In view of the potentially high risks associated with
counsellors administering psychotherapeutic interventions
in a vulnerable population (traumatized adolescents with
PTSD), a Data Safety and Monitoring Board (DSMB) will
be established for this trial. The DSMB will include a child
psychiatrist, clinical psychologist, statistician and an
ethicist. The DSMB will meet at regular intervals upon
completion of the pilot study, as well as every 6 months
during the study, to review cumulative data and to evalu-
ate the safety of human participants, study conduct, and
the scientific validity and integrity of the data. The DSMB
will report back on its findings to the study team and to
the Health Research Ethics Committee (Faculty of Health
Sciences, Stellenbosch University) via the Principal In-
vestigator. Audio-recordings will be stored in a locked
cabinet in the researcher’s office and destroyed after 5 years.
Study implications
Information from this study can directly inform and
benefit both policy makers and participants by guiding
appropriate treatment planning and providing some
therapeutic answers to a population in need. Thus, if the
hypotheses of this study are supported by the data,
dissemination of these treatments, to be delivered by
trained and supervised previously psychotherapy-naïve
health care personnel in general practice would be rec-
ommended. Participants in the treatment study will
benefit from receiving well-delivered treatment for
PTSD and the task-shifted counsellors will benefit from
learning evidence-based effective treatments for PTSD
under close and supportive supervision. Participants may
also benefit from knowing that they have contributed to
the scientific understanding of PTSD and its treatment
that may help other adolescents struggling with similar
problems and their community care providers.
Additional file
Additional file 1: Topic guides and interview schedules for the different
qualitative groups, Written standard operating procedures. (DOCX 84 kb)
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